Featuring Tina Beaumont, Managing Director at Accenture
The pandemic has yielded significant opportunities for BioPharma companies and at the same time has served up unprecedented challenges. Whether your company is a survivor or a thriver during this time, a common denominator is the need to accelerate your digital transformation, replacing technology incumbents with novel, new solutions.
Join us on September 21st at 10am ET/3pm BST for a panel discussion on how BioPharma companies are adapting their operational processes as part of their transformation. Hear how Merck, Johnson & Johnson and Accenture are leveraging innovation solutions such as process mining to maximize their operational capacity.
Tina Beaumont, lead for Accenture’s Northeast US CFO and Enterprise Value Management practice will provide an overview of the current state of affairs for BioPharma organizations and will then lead a panel discussion featuring:
· Marvin Johnson, Sr. Director, Integrated Services Management - J & J
· Jeff Augustin, Vice President Global Business Services - Merck
· Nirav Sampat, Senior Managing Director and CTO of Operations - Accenture Attendees will have the opportunity to raise questions for Tina and the panel.
Reserve your spot today!
Insights to inbox - Monthly newsletter
Master Data-Driven Business Execution. 8 virtual events worldwide.